Silverleafe Capital Partners’s GT Biopharma GTBP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,500	Closed	-$708K	–	89
2021 Q3	$708K	Buy	3,500 +33	+1%	+$6.68K	0.28%	51
2021 Q2	$1.61M	Buy	+3,467	New	+$1.61M	0.62%	46